Aptorum (NASDAQ: APM): Multi-Pillar Drug Development with Near-Term Revenue

0
2



Aptorum Group (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs.